brivaracetam

Generic: brivaracetam

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name brivaracetam
Generic Name brivaracetam
Labeler novadoz pharmaceuticals llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

brivaracetam 25 mg/1

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-268
Product ID 72205-268_11ca0e1d-1c0d-4357-9ebd-ee1e87185dde
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214921
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2025-11-13

Pharmacologic Class

Mechanism of Action
epoxide hydrolase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205268
Hyphenated Format 72205-268

Supplemental Identifiers

RxCUI
1739761 1739768 1739772 1739776 1739780
UPC
0372205270602 0372205267602 0372205271609 0372205268609 0372205269606 0372205271012 0372205268012 0372205269019
UNII
U863JGG2IA
NUI
N0000192345

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brivaracetam (source: ndc)
Generic Name brivaracetam (source: ndc)
Application Number ANDA214921 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (72205-268-06) / 1 TABLET, FILM COATED in 1 BLISTER PACK
  • 60 TABLET, FILM COATED in 1 BOTTLE (72205-268-60)
source: ndc

Packages (2)

72205-268-06 100 BLISTER PACK in 1 CARTON (72205-268-06) / 1 TABLET, FILM COATED in 1 BLISTER PACK 72205-268-60 60 TABLET, FILM COATED in 1 BOTTLE (72205-268-60)

Ingredients (1)

brivaracetam (25 mg/1)

Linked Drug Pages (1)

brivaracetam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "11ca0e1d-1c0d-4357-9ebd-ee1e87185dde", "openfda": {"nui": ["N0000192345"], "upc": ["0372205270602", "0372205267602", "0372205271609", "0372205268609", "0372205269606", "0372205271012", "0372205268012", "0372205269019"], "unii": ["U863JGG2IA"], "rxcui": ["1739761", "1739768", "1739772", "1739776", "1739780"], "spl_set_id": ["11ca0e1d-1c0d-4357-9ebd-ee1e87185dde"], "pharm_class_moa": ["Epoxide Hydrolase Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (72205-268-06)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "72205-268-06", "marketing_start_date": "20260201"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72205-268-60)", "package_ndc": "72205-268-60", "marketing_start_date": "20260201"}], "brand_name": "brivaracetam", "product_id": "72205-268_11ca0e1d-1c0d-4357-9ebd-ee1e87185dde", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Epoxide Hydrolase Inhibitors [MoA]"], "product_ndc": "72205-268", "dea_schedule": "CV", "generic_name": "brivaracetam", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "brivaracetam", "active_ingredients": [{"name": "BRIVARACETAM", "strength": "25 mg/1"}], "application_number": "ANDA214921", "marketing_category": "ANDA", "marketing_start_date": "20251113", "listing_expiration_date": "20261231"}